Adaptive Pharmacogenomics, LLC

Clinical development for personalized medicine

Tuesday, February 7, 2012 | 5:26 PM

VBI researchers develop new method for breast cancer biomarker discovery

Three researchers from the Virginia Bioinformatics Institute (VBI) at Virginia Tech have developed and evaluated a new one-step bioanalytical approach that allows them to profile in detail complex cellular extracts of proteins. The method has allowed the scientists to look at how the levels of proteins change in breast cancer cells when they are treated with hormones or cancer drugs like tamoxifen.
Jun 09, 2009 12:00 AMwww.eurekalert.org
© 2008 — 2012 Adaptive Pharmacogenomics, LLC